Aris ANGELIS

Dr Aris Angelis is Secretery General for Strategic Planning at Greek Ministry of Health, reporting to the Minister of Health. Among his responsibilities include all aspects of national pharmaceutical policy and regulation, national coverage provisions, digital health and strategic planning, as well as the coordination of the implementation of relevant actions and projects of the RRF.
As part of the Ministry of Health political leadership, he represents Greece in European fora, such as the EU EPSCO Health Ministers’ Council, negotiating the country’s positions, including the negotiation of relevant legislative acts (e.g. the EU Pharmaceutical Package, the Critical Medicines Act, the Regulation on the European Health Data Space), whereas has also the responsibility for the implementation of relevant EU directives and regulations (e.g. the Falsified Medicines Directive, the Health Technology Assessment Regulation). Additionally, he has assumed various roles, representing Greece at EMA’s Committee for Medicinal Products for Human Use (CHMP), OECD’s Health Committee, WHO Novel Medicines Platform, HERA Joint Procurement Agreements and HERA Joint Industrial Cooperation Forum. Dr Angelis received his Doctor of Philosophy (PhD) in Health Policy and Economics from the LSE. He also holds an MSc in International Health Policy from the LSE, an MSc in Biopharmacy from King’s College London and a BSc in Biochemistry from Imperial College London.